ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript May 14, 2025
ADC Therapeutics SA beats earnings expectations. Reported EPS is $-0.36, expectations were $-0.38.
Operator: Good morning, ladies and gentlemen, and welcome to ADC Therapeutics’ First Quarter 2025 Earnings Call. [Operator Instructions] I would now like to turn the conference call over to Marcy Graham, Investor Relations and Corporate Affairs Officer. Please go ahead.
Marcy Graham: Thank you, operators. Today, we...
